Adrenergic control of protein metabolism in skeletal muscle

被引:57
作者
Navegantes, LCC
Migliorini, RH
Kettelhut, ID
机构
[1] Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Dept Physiol, Sch Med, BR-14049900 Ribeirao Preto, SP, Brazil
关键词
D O I
10.1097/00075197-200205000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review summarizes evidence indicating that the sympathetic nervous system, through hormonal and neurotransmitter actions, produces anabolic, protein-sparing effects on skeletal muscle protein metabolism. Studies are reviewed which indicate that catecholamines secreted by the adrenal medulla have an inhibitory effect on muscle Ca2+-dependent protein degradation independently of other hormones. In addition, norepinephrine released from adrenergic terminals may increase the rate of protein synthesis in oxidative muscles, leading to increased protein accretion. Evidence is also presented that these effects seem to be mediated by beta(2)-adrenoceptors and cyclic adenosine monophosphate-dependent pathways, The understanding of the precise mechanisms by which endogenous catecholamines promote muscle anabolic effects may bring new perspectives for efficient treatment of muscle-wasting conditions and enhancement of growth efficacy in farm species. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 55 条
[11]   EFFECTS OF THE BETA-2-ADRENOCEPTOR AGONIST, CLENBUTEROL, ON MUSCLE ATROPHY DUE TO FOOD-DEPRIVATION IN THE RAT [J].
CHOO, JJ ;
HORAN, MA ;
LITTLE, RA ;
ROTHWELL, NJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (06) :647-650
[12]   Magnetic resonance imaging of denervation-induced muscle atrophy: Effects of clenbuterol in the rat [J].
Cockman, MD ;
Jones, MB ;
Prenger, MC ;
Sheldon, RJ .
MUSCLE & NERVE, 2001, 24 (12) :1647-1658
[13]  
Cong JY, 2000, MOL BIOL CELL, V11, p386A
[14]   The bovine calpastatin gene promoter and a new N-terminal region of the protein are targets for cAMP-dependent protein kinase activity [J].
Cong, M ;
Thompson, VF ;
Goll, DE ;
Antin, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :660-666
[15]   cAMP responsiveness of the bovine calpastatin gene promoter [J].
Cong, M ;
Goll, DE ;
Antin, PB .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1443 (1-2) :186-192
[16]   MUSCLE PROTEIN WASTE IN TUMOR-BEARING RATS IS EFFECTIVELY ANTAGONIZED BY A BETA(2)-ADRENERGIC AGONIST (CLENBUTEROL) - ROLE OF THE ATP-UBIQUITIN-DEPENDENT PROTEOLYTIC PATHWAY [J].
COSTELLI, P ;
GARCIAMARTINEZ, C ;
LLOVERA, M ;
CARBO, N ;
LOPEZSORIANO, FJ ;
AGELL, N ;
TESSITORE, L ;
BACCINO, FM ;
ARGILES, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2367-2372
[17]   Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia [J].
Costelli, P ;
De Tullio, R ;
Baccino, FM ;
Melloni, E .
BRITISH JOURNAL OF CANCER, 2001, 84 (07) :946-950
[18]   Dantrolene reduces serum TNFα and corticosterone levels and muscle calcium, calpain gene expression, and protein breakdown in septic rats [J].
Fischer, DR ;
Sun, XY ;
Williams, AB ;
Gang, G ;
Pritts, TA ;
James, JH ;
Molloy, M ;
Fischer, JE ;
Paul, RJ ;
Hasselgren, PO .
SHOCK, 2001, 15 (03) :200-207
[19]   The calpain system and skeletal muscle growth [J].
Goll, DE ;
Thompson, VF ;
Taylor, RG ;
Ouali, A .
CANADIAN JOURNAL OF ANIMAL SCIENCE, 1998, 78 (04) :503-512
[20]  
GOLL DE, 1999, CALPAIN PHARM TOXICO, P127